Small cell neuroendocrine carcinoma of the urinary bladder: case report of a rare primary tumor.
Primary small cell neuroendocrine carcinoma of the bladder is a rare condition, with fewer than 140 cases having been reported. It is an aggressive tumor with an average five-year survival rate of less than 10 percent as cited by multiple case reports. We report a 73-year-old white woman with primary small cell neuroendocrine carcinoma of the bladder who was treated with radical cystectomy and adjuvant cisplatin/etoposide-based chemotherapy.
McClellan
T
T
West Virginia University School of Medicine, Charleston Division, USA.
DeBord
J
J
Franklin
G
G
Tierney
J
J
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000453:epidemiology* / Q000628:therapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D015653:Cystectomy; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology* / Q000628:therapy
D005047:Etoposide; D002945:Cisplatin